Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

D.C. Rijkaart, J. Berkhof, L. Rozendaal, F.J. van Kemenade, N.W.J. Bulkmans, D.A.M. Heideman, G.G. Kenter, J. Cuzick, P.J.F. Snijders, C.J.L.M. Meijer

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)78-88
JournalLancet Oncology
Volume13
Issue number1
DOIs
Publication statusPublished - 2012

Cite this

@article{cc8fe1b0be294268868ff778d5f7e808,
title = "Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial",
author = "D.C. Rijkaart and J. Berkhof and L. Rozendaal and {van Kemenade}, F.J. and N.W.J. Bulkmans and D.A.M. Heideman and G.G. Kenter and J. Cuzick and P.J.F. Snijders and C.J.L.M. Meijer",
year = "2012",
doi = "10.1016/S1470-2045(11)70296-0",
language = "English",
volume = "13",
pages = "78--88",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "1",

}

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. / Rijkaart, D.C.; Berkhof, J.; Rozendaal, L.; van Kemenade, F.J.; Bulkmans, N.W.J.; Heideman, D.A.M.; Kenter, G.G.; Cuzick, J.; Snijders, P.J.F.; Meijer, C.J.L.M.

In: Lancet Oncology, Vol. 13, No. 1, 2012, p. 78-88.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

AU - Rijkaart, D.C.

AU - Berkhof, J.

AU - Rozendaal, L.

AU - van Kemenade, F.J.

AU - Bulkmans, N.W.J.

AU - Heideman, D.A.M.

AU - Kenter, G.G.

AU - Cuzick, J.

AU - Snijders, P.J.F.

AU - Meijer, C.J.L.M.

PY - 2012

Y1 - 2012

U2 - 10.1016/S1470-2045(11)70296-0

DO - 10.1016/S1470-2045(11)70296-0

M3 - Article

VL - 13

SP - 78

EP - 88

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 1

ER -